Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Open accessThe DOI matches its Crossref record; 355 of the 355 references it cites were found in a registry or an index.
Abstract
The Wnt/β-catenin signaling pathway plays a crucial role in various physiological processes, encompassing development, tissue homeostasis, and cell proliferation. Under normal physiological conditions, the Wnt/β-catenin signaling pathway is meticulously regulated. However, aberrant activation of this pathway and downstream target genes can occur due to mutations in key components of the Wnt/β-catenin pathway, epigenetic modifications, and crosstalk with other signaling pathways. Consequently, these dysregulations contribute significantly to tumor initiation and progression. Therapies targeting the Wnt/β-catenin signaling transduction have exhibited promising prospects and potential for tumor treatment. An increasing number of medications targeting this pathway are continuously being developed and validated. This comprehensive review aims to summarize the latest advances in our understanding of the role played by the Wnt/β-catenin signaling pathway in carcinogenesis and targeted therapy, providing valuable insights into acknowledging current opportunities and challenges associated with targeting this signaling pathway in cancer research and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Wnt/β-catenin pathway is a well-established oncogenic driver in numerous cancers, including ccRCC, where its aberrant activation is linked to tumor initiation and progression [30–32].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wu, L., He, S., He, Y., Wang, X., & Lu, L. (2018) · Medical Science Monitor · doi:10.12659/msm.910742 · Cited by 14 · cited 1×
“IC-2, a small molecule inhibitor, effectively diminishes the population of CD44 cells (liver CSCs) and impedes sphere-forming capacity in HCC, CRC, and bladder cancer cells [343–345].”
BackgroundRetractedComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499 · cited 1×
“The Wnt signaling pathway alterations are universally observed in CRC tissues, with more than 90% of CRC cases harboring mutations in genes such as APC, CTNNB1, RNF42, AXIN1, or RSPO [196].”
BackgroundIdentification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687 · cited 1×
“Several characteristics have been identified in stem cells, including Lgr5, Bmi1, Lrig1 and Dclk1 [205–207].”
BackgroundWnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Integrative Clinical Genomics of Advanced Prostate Cancer
Robinson, D., Van Allen, E. M., Wu, Y.-M., Schultz, N., Lonigro, R. J., Mosquera, J.-M., Montgomery, B., Taplin, M.-E., Pritchard, C. C., Attard, G., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.001 · Cited by 3,645 · cited 1×
“…that activation of Wnt/β-catenin signaling due to genetic changes occurs more frequently in castration-resistant prostate cancer (CRPC) compared to treatment-naïve cases, as evidenced by clinical samples obtained from CRPC patients, which demonstrate alterations in CTNNB1 and APC genes [237].”
BackgroundWnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00762-6 · Cited by 2,519 · cited 1×
“…chloroquine is an FDA-approved drug commonly utilized for treating tapeworm infection and stands out due to its mechanism involving internalization of the FZD1 receptor, reduction in DVL2 protein levels, and targeting of LRP6 to impede tumor proliferation, stemness, and metastasis [356, 357].”
BackgroundTankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037 · cited 1×
“Several TNKS inhibitors with favorable therapeutic effects have been developed, including XAV939, G007LK, G244-LM, RK-287,107, JW55, K-756, IWR-1, MSC2504877, AZ1366, JW74, and NVP-TNKS656 [308–317].”
BackgroundWNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911 · cited 1×
“The downstream effector in this cascade is β-catenin which serves as a vital component of the canonical Wnt pathway [25].”
BackgroundNusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863 · cited 1×
“The Wnt gene is synonymous with the Drosophila segment polarity gene Wingless and the murine proto-onco-gene integration 1, which was molecularly characterized from mouse tumor cells in 1982 [14].”
BackgroundThe many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598
Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536 · cited 1×
“The APC multiple intestinal neoplasias mouse model has been employed to investigate intestinal cancer [200, 201].”
BackgroundWnt signal transduction pathways
Komiya, Y., & Habas, R. (2008) · Organogenesis · doi:10.4161/org.4.2.5851 · Cited by 1,528 · cited 1×
“Upon binding of Wnt to FZD and LRP5/6 receptors, the signaling pathway is initiated [24].”
BackgroundTargeting the Wnt/β-catenin signaling pathway in cancer
Zhang, Y., & Wang, X. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00990-3 · Cited by 1,431 · cited 2×
“…as an inhibitor of the Wnt/β-catenin pathway and demonstrates selective anti-tumor properties by targeting ovarian CSCs. Additionally, chloroquine reduces the levels of CSCs and their self-renewal ability in basal-like breast cancer through downregulation of LRP6 and β-catenin expression [341].”
BackgroundSherman, M. H., Yu, R. T., Engle, D. D., Ding, N., Atkins, A. R., Tiriac, H., Collisson, E. A., Connor, F., Van Dyke, T., Kozlov, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.007 · Cited by 1,158
YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response
Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.013 · Cited by 1,094 · cited 1×
“In the absence of Wnt ligands, TAZ and YAP are recruited alongside β-TrCP, which initiates the degradation of β-catenin [180].”
BackgroundLDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:Arrows point the way
He, X., Semenov, M., Tamai, K., & Zeng, X. (2004) · Development · doi:10.1242/dev.01117 · Cited by 1,044 · cited 1×
“FZD protein are seven-span transmembrane receptors that are associated with low-density lipoprotein receptor 5 (LRP5) and LRP6, acting as co-receptors for FZD [17, 19, 22, 23].”
BackgroundKremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling
Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C., et al. (2002) · Nature · doi:10.1038/nature756 · Cited by 1,038
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034 · cited 1×
“Therefore, the clinical application of these therapies is limited [358, 359].”
BackgroundTargeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Krishnamurthy, N., & Kurzrock, R. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.002 · Cited by 1,026 · cited 2×
“Inhibitors targeting PORCN have the ability to effectively suppress the post-translational acylation process of Wnt ligands, thereby impeding their secretion [278].”
BackgroundFunction and biological roles of the Dickkopf family of Wnt modulators
Niehrs, C. (2006) · Oncogene · doi:10.1038/sj.onc.1210054 · Cited by 995 · cited 1×
“The DKK family is widely regarded as an inhibitor of the canonical β-catenin-dependent Wnt pathway [66].”
BackgroundZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
Hao, H.-X., Xie, Y., Zhang, Y., Charlat, O., Oster, E., Avello, M., Lei, H., Mickanin, C., Liu, D., Ruffner, H., et al. (2012) · Nature · doi:10.1038/nature11019 · Cited by 972 · cited 1×
“The ubiquitination of FZD resulting from RNF43/Znrf3 leads to FZD endocytosis and subsequent downregulation of Wnt signaling [61–63].”
BackgroundSatoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960 · cited 1×
“Recent studies have demonstrated that adenovirus-mediated transfer of wild-type AXIN1 gene can elicit apoptosis in HCC and CRC cells that have accumulated β-catenin due to APC, CTNNB1 or AXIN1 mutation [89].”
BackgroundWnt5a signaling directly affects cell motility and invasion of metastatic melanoma
Weeraratna, A. T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M., & Trent, J. M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00045-4 · Cited by 959 · cited 1×
“It is widely postulated that distinct Wnt signaling pathways are harnessed by melanoma cells at different stages of disease advancement; canonical Wnt signaling predominantly facilitates growth and transformation to augment their proliferative capacity [247, 248].”
BackgroundWnt Induces LRP6 Signalosomes and Promotes Dishevelled-Dependent LRP6 Phosphorylation
Bilić, J., Huang, Y.-L., Davidson, G., Zimmermann, T., Cruciat, C.-M., Bienz, M., & Niehrs, C. (2007) · Science · doi:10.1126/science.1137065 · Cited by 934 · cited 2×
“When Wnt ligands bind, DVL is recruited to the plasma membrane, contributing to the formation of clathrin-coated pits, thereby facilitating FZD clustering and LRP6 phosphorylation [29, 33, 39, 40].”
BackgroundSelf-citationWnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857 · cited 2×
“Non-steroidal anti-inflammatory drugs have also been found to block cancer signaling pathways by inhibiting the activation of Wnt/β-catenin and reducing expression of its target genes via inhibition of β-catenin-mediated transcription [355].”
BackgroundSuzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation
Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J., & He, X. (2005) · Nature · doi:10.1038/nature04185 · Cited by 849 · cited 2×
“Its activation is dependent on the binding of Wnt ligands to frizzled serpentine receptors (FZD), initiating this pathway [17–19].”
BackgroundSignaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831 · cited 1×
“Resvera-trol has been incorporated into two phase I clinical trials to investigate its potential in preventing CRC through dietary supplementation and reducing myocardial fibrosis [354].”
MethodTargeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831 · cited 2×
“Among these inhibitors, Wnt974 (LGK974) particularly noteworthy for its demonstrated efficacy in various tumor models including mouse mammary tumor virus-Wnt-1 (MMTV-Wnt1) mouse model and models of human head and neck squamous cell carcinoma [279, 280].”
BackgroundSun, Y., Campisi, J., Higano, C., Beer, T. M., Porter, P., Coleman, I., True, L., & Nelson, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2890 · Cited by 793 · cited 1×
“Consequently, this mechanism diminishes the efficacy of chemotherapy in eradicating cancer cells and fosters the development of drug resistance [239].”
BackgroundA distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
de Sousa e Melo, F., Kurtova, A. V., Harnoss, J. M., Kljavin, N., Hoeck, J. D., Hung, J., Anderson, J. E., Storm, E. E., Modrusan, Z., Koeppen, H., et al. (2017) · Nature · doi:10.1038/nature21713 · Cited by 788 · cited 1×
“The ablation of cells expressing Bmi1 or directly elimination of Lgr5-positive cells has demonstrated a reduction in intestinal tumor burden [208, 209].”
BackgroundThe Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., & Armstrong, S. A. (2010) · Science · doi:10.1126/science.1186624 · Cited by 763
TCF/LEFs and Wnt Signaling in the Nucleus
Cadigan, K. M., & Waterman, M. L. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007906 · Cited by 760 · cited 1×
“Within the context of the Wnt signaling pathway, the TCF/LEF acts as the principal downstream effector and partner of β-catenin [45].”
BackgroundFamilial adenomatous polyposis
Galiatsatos, P., & Foulkes, W. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00375.x · Cited by 757 · cited 1×
“The APC multiple intestinal neoplasias mouse model has been employed to investigate intestinal cancer [200, 201].”
BackgroundDishevelled: The hub of Wnt signaling
Gao, C., & Chen, Y.-G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.021 · Cited by 755
Wnt/β-catenin signaling in cancers and targeted therapies
Yu, F., Yu, C., Li, F., Zuo, Y., Wang, Y., Yao, L., Wu, C., Wang, C., & Ye, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00701-5 · Cited by 734 · cited 3×
“Consequently, extensive research has demonstrated the ability of rosmantuzumab to impede self-renewal and differentiation processes in acute myeloid leukemia cells within PDX models, while simultaneously preserving the normal physiological function of hematopoietic stem cells [347].”
BackgroundThe Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway
Lee, E., Salic, A., Krüger, R., Heinrich, R., & Kirschner, M. W. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000010 · Cited by 708 · cited 1×
“AXIN, a rate-limiting scaffolding protein within the complex, is continuously regulated by TNKS [304–306].”
BackgroundThe R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength
de Lau, W., Peng, W. C., Gros, P., & Clevers, H. (2014) · Genes & Development · doi:10.1101/gad.235473.113 · Cited by 656 · cited 1×
“The ubiquitination of FZD resulting from RNF43/Znrf3 leads to FZD endocytosis and subsequent downregulation of Wnt signaling [61–63].”
BackgroundSmall-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653
Unexpected complexity of the Wnt gene family in a sea anemone
Kusserow, A., Pang, K., Sturm, C., Hrouda, M., Lentfer, J., Schmidt, H. A., Technau, U., von Haeseler, A., Hobmayer, B., Martindale, M. Q., et al. (2005) · Nature · doi:10.1038/nature03158 · Cited by 599 · cited 1×
“The Wnt protein family consists of 19 types of secreted proteins found in the human body [30].”
BackgroundInternational Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J.-P., Davenport, A. P., Spedding, M., & Harmar, A. J. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.5 · Cited by 592 · cited 1×
“FZD proteins, which are transmembrane receptors located on the plasma membrane, consist of seven domains [32].”
BackgroundWnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xu, X., Zhang, M., Xu, F., & Jiang, S. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01276-5 · Cited by 588 · cited 2×
“In brief, abnormalities in the Wnt signaling pathway play a critical role in breast carcinogenesis, and therefore necessitate thorough and meticulous investigation [231].”
BackgroundGlobal Epidemiology and Genetics of Hepatocellular Carcinoma
Toh, M. R., Wong, E. Y. T., Wong, S. H., Ng, A. W. T., Loo, L.-H., Chow, P. K.-H., & Ngeow, J. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.033 · Cited by 583 · cited 1×
“Hepatocellular carcinoma HCC is one of the most prevalent carcinomas worldwide and a leading cause of cancer-related death [215].”
BackgroundThe Hippo Pathway Regulates Wnt/β-Catenin Signaling
Varelas, X., Miller, B. W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F. A., Sakuma, R., Pawson, T., Hunziker, W., McNeill, H., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.007 · Cited by 569 · cited 1×
“Suppression of TAZ results in the stabilization of β-catenin, leading to the accumulation of nuclear β-catenin and phosphorylation of DVL [181].”
BackgroundCrosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
Ma, B., & Hottiger, M. O. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00378 · Cited by 563
LGR4 and LGR5 are R‐spondin receptors mediating Wnt/β‐catenin and Wnt/PCP signalling
Glinka, A., Dolde, C., Kirsch, N., Huang, Y., Kazanskaya, O., Ingelfinger, D., Boutros, M., Cruciat, C., & Niehrs, C. (2011) · EMBO reports · doi:10.1038/embor.2011.175 · Cited by 562 · cited 1×
“Furthermore, they can inhibit the activity of Ring finger protein 43 (RNF43) / Zinc and ring finger 3 (ZNRF3) by binding to them, which are ubiquitin ligases located on the plasma membrane responsible for multiubiquitination of lysine [60].”
BackgroundSelf-citationDKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway
Niida, A., Hiroko, T., Kasai, M., Furukawa, Y., Nakamura, Y., Suzuki, Y., Sugano, S., & Akiyama, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207892 · Cited by 554 · cited 1×
“Therefore, DKKs would turn down the Wnt/β-catenin signaling, offering a negative feedback mechanism to manipulate Wnt signaling [69, 70].”
BackgroundKühl, M., Sheldahl, L. C., Malbon, C. C., & Moon, R. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12701 · Cited by 517 · cited 1×
“Their crucial role in development has been established by extensive research [15, 16], although further investigations are warranted.”
BackgroundHan, P., Li, J.-W., Zhang, B.-M., Lv, J.-C., Li, Y.-M., Gu, X.-Y., Yu, Z.-W., Jia, Y.-H., Bai, X.-F., Li, L., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0583-1 · Cited by 496 · cited 1×
“…it has been validated that lncRNA-LINC01133 inhibits miR-106a-3p in gastric cancer, thereby regulating the Wnt signaling pathway negatively [144]. lncRNA-CRNDE has also been observed to play its role in inhibiting miR-181a-5p, thereby promoting the progression and chemoresistance of CRC [159].”
BackgroundSelf-citationZeng, X., Huang, H., Tamai, K., Zhang, X., Harada, Y., Yokota, C., Almeida, K., Wang, J., Doble, B., Woodgett, J., et al. (2008) · Development · doi:10.1242/dev.013540 · Cited by 492 · cited 1×
“When Wnt ligands bind, DVL is recruited to the plasma membrane, contributing to the formation of clathrin-coated pits, thereby facilitating FZD clustering and LRP6 phosphorylation [29, 33, 39, 40].”
BackgroundA Mechanism for Wnt Coreceptor Activation
Tamai, K., Zeng, X., Liu, C., Zhang, X., Harada, Y., Chang, Z., & He, X. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00484-2 · Cited by 490 · cited 1×
“Within the intracellular domain of LRP5/6, the serine/threonine phosphorylation of the PPPSxPS motif is conserved, providing a docking site for AXIN binding [36] as well as presenting a critical step in initiating Wnt/β-catenin signal transduction [37, 38].”
BackgroundSmall-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485 · cited 1×
“It effectively stabilizes AXIN and facilitates β-catenin turnover, thereby inhibiting Wnt signal transduction [319].”
BackgroundMultiple Roles of APC and its Therapeutic Implications in Colorectal Cancer
Zhang, L., & Shay, J. W. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw332 · Cited by 449 · cited 3×
“The APC gene, initially identified as a mutated gene in familial adenomatous polyposis coli (FAP), is also detected in 80% of colorectal adenomas and colorectal carcinomas (CRCs), positioning it as one of the earliest mutations in the development of colon cancer [82, 83].”
BackgroundActivation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular Carcinoma
Yamashita, T., Budhu, A., Forgues, M., & Wang, X. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0908 · Cited by 446 · cited 1×
“PKF115-854 and CGP049090 have also presented inhibitory effects on HCC cell growth [327, 328].”
BackgroundNotum deacylates Wnt proteins to suppress signalling activity
Kakugawa, S., Langton, P. F., Zebisch, M., Howell, S. A., Chang, T.-H., Liu, Y., Feizi, T., Bineva, G., O’Reilly, N., Snijders, A. P., et al. (2015) · Nature · doi:10.1038/nature14259 · Cited by 446 · cited 1×
“Notum also functions as an enzyme-like inhibitor of Wnt signaling with evidence suggesting that tumor cells suppress normal cells through secretion of notum [56, 57].”
BackgroundSelf-citationWnt-dependent Regulation of the E-cadherin Repressor Snail
Yook, J. I., Li, X.-Y., Ota, I., Fearon, E. R., & Weiss, S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413878200 · Cited by 445 · cited 1×
“Consequently, the induction of EMT promotes tumor metastasis [194].”
BackgroundR-Spondin2 Is a Secreted Activator of Wnt/β-Catenin Signaling and Is Required for Xenopus Myogenesis
Kazanskaya, O., Glinka, A., del Barco Barrantes, I., Stannek, P., Niehrs, C., & Wu, W. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.07.019 · Cited by 431 · cited 1×
“This effect was initially discovered in Xenopus embryos, and it was also observed that mouse R-spodin1-3 exhibits a similar effect [59].”
BackgroundLu, Y., Zhao, X., Liu, Q., Li, C., Graves-Deal, R., Cao, Z., Singh, B., Franklin, J. L., Wang, J., Hu, H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4424 · Cited by 425 · cited 1×
“Evidence suggests that miR-106a-3p, miR-494, miR-100, miR-125b, and miR-155 possess the capacity to directly inhibit APC, leading to β-catenin translocation and subsequent transcriptional activation of target genes [142–145].”
BackgroundJung, Y.-S., & Park, J.-I. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0380-6 · Cited by 419 · cited 1×
“Niclosamide, calcipotriol, Salinomycin, pantoprazole and monensin downregulates the total and p-LRP6, leading to its degradation and inhibition of Wnt/ β-catenin signaling pathway [294, 295].”
BackgroundTherapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
Cheng, X., Xu, X., Chen, D., Zhao, F., & Wang, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.082 · Cited by 417
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
Jiang, X., Hao, H.-X., Growney, J. D., Woolfenden, S., Bottiglio, C., Ng, N., Lu, B., Hsieh, M. H., Bagdasarian, L., Meyer, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307218110 · Cited by 414
Biology of the Adenomatous Polyposis Coli Tumor Suppressor
Goss, K. H., & Groden, J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1967 · Cited by 400 · cited 1×
“The APC gene, initially identified as a mutated gene in familial adenomatous polyposis coli (FAP), is also detected in 80% of colorectal adenomas and colorectal carcinomas (CRCs), positioning it as one of the earliest mutations in the development of colon cancer [82, 83].”
BackgroundYang, X.-Z., Cheng, T.-T., He, Q.-J., Lei, Z.-Y., Chi, J., Tang, Z., Liao, Q.-X., Zhang, H., Zeng, L.-S., & Cui, S.-Z. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0874-1 · Cited by 386 · cited 1×
“…it has been validated that lncRNA-LINC01133 inhibits miR-106a-3p in gastric cancer, thereby regulating the Wnt signaling pathway negatively [144]. lncRNA-CRNDE has also been observed to play its role in inhibiting miR-181a-5p, thereby promoting the progression and chemoresistance of CRC…”
BackgroundFrom Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Ntziachristos, P., Lim, J. S., Sage, J., & Aifantis, I. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.018 · Cited by 374 · cited 1×
“The Notch signaling pathway is a conserved ligand-receptor signaling cascade in mammals, encompassing 5 ligands and 4 receptors that exhibit a similar structural framework [175].”
BackgroundGeyer, F. C., Lacroix-Triki, M., Savage, K., Arnedos, M., Lambros, M. B., MacKay, A., Natrajan, R., & Reis-Filho, J. S. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.205 · Cited by 373 · cited 1×
“IDC demonstrates consistent expression of β-catenin, both in the membrane and nucleus [229].”
BackgroundMulti-targeted therapy of cancer by niclosamide: A new application for an old drug
Li, Y., Li, P.-K., Roberts, M. J., Arend, R. C., Samant, R. S., & Buchsbaum, D. J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.003 · Cited by 364 · cited 1×
“Niclosamide facilitates the endocytosis of FZD1, leading to the down-regulation of Wnt3a-induced β-catenin stabilization [291].”
BackgroundZhang, M., Weng, W., Zhang, Q., Wu, Y., Ni, S., Tan, C., Xu, M., Sun, H., Liu, C., Wei, P., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0656-7 · Cited by 362 · cited 1×
“In various cancer categories, it has been observed that lncRNA-NEAT1 is able to interact with DDX and augment gene transcription [157].”
BackgroundOsteosarcoma Development and Stem Cell Differentiation
Tang, N., Song, W.-X., Luo, J., Haydon, R. C., & He, T.-C. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0335-z · Cited by 357 · cited 1×
“Osteosarcoma Osteosarcoma (OS) is a disease characterized by aberrant cellular differentiation, which arises from the transformation of pluripotent MSCs [265].”
BackgroundWillert, K., & Nusse, R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007864 · Cited by 353 · cited 1×
“The Wnt family consists of numerous members with 19 Wnt genes in humans [20].”
BackgroundWNT Signaling in Cardiac and Vascular Disease
Foulquier, S., Daskalopoulos, E. P., Lluri, G., Hermans, K. C. M., Deb, A., & Blankesteijn, W. M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.013896 · Cited by 347
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
Madan, B., Ke, Z., Harmston, N., Ho, S. Y., Frois, A. O., Alam, J., Jeyaraj, D. A., Pendharkar, V, Ghosh, K., Virshup, I. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.280 · Cited by 341 · cited 1×
“It has exhibited significant therapeutic effects in xenografts derived from CRC patients harboring RSPO translocations [282].”
BackgroundChien, A. J., Moore, E. C., Lonsdorf, A. S., Kulikauskas, R. M., Rothberg, B. G., Berger, A. J., Major, M. B., Hwang, S. T., Rimm, D. L., & Moon, R. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811902106 · Cited by 332 · cited 1×
“The role of β-catenin in the later stages of melanoma development remains controversial, as some studies propose that elevated levels of β-catenin in melanoma are associated with a lower proliferative index [243] or a better prognosis [244].”
BackgroundMicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
Cai, J., Guan, H., Fang, L., Yang, Y., Zhu, X., Yuan, J., Wu, J., & Li, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65871 · Cited by 331 · cited 1×
“The overexpression of miR-374a in breast cancer enhances the nuclear translocation of β-catenin, thereby promoting the transcriptional activity of TCF/LEF [141].”
BackgroundPan, J., Fang, S., Tian, H., Zhou, C., Zhao, X., Tian, H., He, J., Shen, W., Meng, X., Jin, X., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1133-9 · Cited by 330
Chang, J., Liu, F., Lee, M., Wu, B., Ting, K., Zara, J. N., Soo, C., Al Hezaimi, K., Zou, W., Chen, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300532110 · Cited by 329
Waaler, J., Machon, O., Tumova, L., Dinh, H., Korinek, V., Wilson, S. R., Paulsen, J. E., Pedersen, N. M., Eide, T. J., Machonova, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3336 · Cited by 328
MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer
Zhang, Y., Guo, L., Li, Y., Feng, G.-H., Teng, F., Li, W., & Zhou, Q. (2018) · Molecular Cancer · doi:10.1186/s12943-017-0753-1 · Cited by 326
A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation–Driven Colorectal Tumor Growth
Lau, T., Chan, E., Callow, M., Waaler, J., Boggs, J., Blake, R. A., Magnuson, S., Sambrone, A., Schutten, M., Firestein, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4562 · Cited by 316
Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
WU, R. T., Zhai, Y., Fearon, E. R., & Cho, K. R. (2001) · PubMed · Cited by 308
β-Catenin signaling in hepatocellular carcinoma
Xu, C., Xu, Z., Zhang, Y., Evert, M., Calvisi, D. F., & Chen, X. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154515 · Cited by 305 · cited 1×
“Although β-catenin has been associated with early-stage HCC, its prognostic significance remains controversial [218].”
BackgroundMa, Y., Yang, Y., Wang, F., Moyer, M.-P., Wei, Q., Zhang, P., Yang, Z., Liu, W., Zhang, H., Chen, N., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308392 · Cited by 304 · cited 1×
“An example in point is AP-2α, a negative regulator that impedes the interaction of β-catenin and TCF4. lncRNA-CCAL has been verified to target AP-2α, giving rise to MDR1/P-gp expression upregulation as well as the development of multi-drug resistance (MDR) in CRC [156].”
BackgroundZhang, Y., Wei, W., Cheng, N., Wang, K., Li, B., Jiang, X., & Sun, S. (2012) · Hepatology · doi:10.1002/hep.25849 · Cited by 300 · cited 1×
“Evidence suggests that miR-106a-3p, miR-494, miR-100, miR-125b, and miR-155 possess the capacity to directly inhibit APC, leading to β-catenin translocation and subsequent transcriptional activation of target genes [142–145].”
BackgroundHsu, H.-C., Jeng, Y.-M., Mao, T.-L., Chu, J.-S., Lai, P.-L., & Peng, S.-Y. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64590-7 · Cited by 294 · cited 1×
“The CTNNB1 mutation represents one of the most crucial genetic events in human HCC, characterized by an increased prevalence of β-catenin overexpression and mutations in hepatitis C virus related HCC compared to hepatitis B virus related cases [216, 217].”
BackgroundNam, J.-S., Turcotte, T. J., Smith, P. F., Choi, S., & Yoon, J. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508324200 · Cited by 288 · cited 1×
“The RSPO family comprises four members (RSPO1-4) that share a similar structure enabling interaction with LGR4-6, LPR5/6, ZNRF3/RNF43, FZD, and heparan sulfate proteoglycans [202].”
BackgroundEpithelial-mesenchymal transition in glioblastoma progression
IWADATE, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4113 · Cited by 288 · cited 1×
“Mesenchymal stem cells (MSCs), a type of pluripotent stem cells derived from the mesoderm, possess robust migratory capacity and resistance to genotoxic substances attributed to the EMT undergone by polarized epithelial cells [261, 263].”
BackgroundWNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Martin-Orozco, E., Sanchez-Fernandez, A., Ortiz-Parra, I., & Ayala-San Nicolas, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02854 · Cited by 286 · cited 1×
“This event plays a significant role in the process of carcinogenesis, leading to resistance development to chemotherapy and immune evasion potentially [195].”
BackgroundDishevelled and Wnt signaling: is the nucleus the final frontier?
Habas, R., & Dawid, I. B. (2005) · Journal of Biology · doi:10.1186/jbiol22 · Cited by 285 · cited 2×
“Its activation is dependent on the binding of Wnt ligands to frizzled serpentine receptors (FZD), initiating this pathway [17–19].”
BackgroundWnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
Patel, S., Alam, A., Pant, R., & Chattopadhyay, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02872 · Cited by 285 · cited 1×
“Dysregulated Wnt signaling orchestrates intricate interactions between transformed cells and infiltrating immune cells, thereby fostering immune tolerance and constraining anti-tumor responses [212].”
BackgroundWnt/β-catenin signalling in prostate cancer
Kypta, R. M., & Waxman, J. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.116 · Cited by 275 · cited 4×
“The secretion of Wnt by prostate stromal cells significantly influences tumorigenesis and progression [235].”
BackgroundInfluentialHuang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., & Ohgaki, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65496-x · Cited by 274
Mohseny, A. B., Szuhai, K., Romeo, S., Buddingh, E. P., Briaire‐de Bruijn, I., de Jong, D., van Pel, M., Cleton‐Jansen, A., & Hogendoorn, P. C. (2009) · The Journal of Pathology · doi:10.1002/path.2603 · Cited by 269 · cited 1×
“In mice, the absence of the CDKN2A locus promotes the formation of OS [266].”
BackgroundBiochemical interactions in the wnt pathway
Seidensticker, M. J., & Behrens, J. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00158-5 · Cited by 261 · cited 1×
“With the activation of the Wnt/β-catenin signaling pathway, DVL recruits AXIN and GSK3β to the plasma membrane, thereby inhibiting their functions [39, 44].”
BackgroundDeletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
Dahmen, R. P., Koch, A., Denkhaus, D., Tonn, J.-C., Sörensen, N., Berthold, F., Behrens, J., Birchmeier, W., Wiestler, O. D., & Pietsch, T. (2001) · PubMed · Cited by 261
Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells
Ghasemi, F., Shafiee, M., Banikazemi, Z., Pourhanifeh, M. H., Khanbabaei, H., Shamshirian, A., Amiri Moghadam, S., ArefNezhad, R., Sahebkar, A., Avan, A., et al. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152556 · Cited by 259
WNT as a Driver and Dependency in Cancer
Parsons, M. J., Tammela, T., & Dow, L. E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0190 · Cited by 257 · cited 1×
“The up-regulation of the Wnt/β-catenin signaling pathway has been implicated in carcinogenesis across various tissues, including colorectal, gastric, and prostate, etc [192].”
BackgroundNOTUM from Apc-mutant cells biases clonal competition to initiate cancer
Flanagan, D. J., Pentinmikko, N., Luopajärvi, K., Willis, N. J., Gilroy, K., Raven, A. P., Mcgarry, L., Englund, J. I., Webb, A. T., Scharaw, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03525-z · Cited by 255 · cited 1×
“Notum also functions as an enzyme-like inhibitor of Wnt signaling with evidence suggesting that tumor cells suppress normal cells through secretion of notum [56, 57].”
BackgroundJagged 1 is a β-catenin target gene required for ectopic hair follicle formation in adult epidermis
Estrach, S., Ambler, C. A., Lo Celso, C. L., Hozumi, K., & Watt, F. M. (2006) · Development · doi:10.1242/dev.02644 · Cited by 254 · cited 1×
“This intricate interplay ultimately leads to the expansion of the base of the hair follicle, sebaceous gland enlargement and abnormal clumping of the follicles [176].”
BackgroundTargeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Le, P. N., McDermott, J. D., & Jimeno, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.08.005 · Cited by 253 · cited 1×
“OMP-54F28, also known as ipafricept, represents a fusion protein integrating CRD of FZD8 and the immunoglobulin Fc domain [349].”
BackgroundLi, B., Cao, Y., Meng, G., Qian, L., Xu, T., Yan, C., Luo, O., Wang, S., Wei, J., Ding, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.063 · Cited by 245
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
Barzegar Behrooz, A., Talaie, Z., Jusheghani, F., Łos, M. J., Klonisch, T., & Ghavami, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031353 · Cited by 240 · cited 4×
“Increased binding of cadherin to α-or β-catenin promotes the migration of glioma cells and EMT [261].”
BackgroundInfluentialWnt signalling: conquering complexity
Wiese, K. E., Nusse, R., & van Amerongen, R. (2018) · Development · doi:10.1242/dev.165902 · Cited by 239 · cited 1×
“Within this degradation complex, GSK3β and CK1α facilitate the phosphorylation of β-catenin, resulting in its ubiquitination and subsequent proteasomal degradation [27, 28].”
BackgroundWnt signaling pathway in cancer immunotherapy
Zhou, Y., Xu, J., Luo, H., Meng, X., Chen, M., & Zhu, D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2021.10.034 · Cited by 233 · cited 1×
“Dysregulated Wnt signaling has been increasingly demonstrated to be associated with a range of cancers including liver, lung, and breast cancers [81].”
BackgroundFujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L. R., Neale, G., Zheng, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2726 · Cited by 232
lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Zhu, P., Wang, Y., Huang, G., Ye, B., Liu, B., Wu, J., Du, Y., He, L., & Fan, Z. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3235 · Cited by 231 · cited 1×
“This event improves β-catenin stability and promotes Wnt/β-catenin signaling [158].”
BackgroundLiu, Y., Patel, L., Mills, G. B., Lu, K. H., Sood, A. K., Ding, L., Kucherlapati, R., Mardis, E. R., Levine, D. A., Shmulevich, I., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju245 · Cited by 228
Self-citationRegulation of Wnt/β-catenin signaling by posttranslational modifications
Gao, C., Xiao, G., & Hu, J. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-13 · Cited by 226 · cited 1×
“Nonetheless, the regulatory effects of acetylation on other molecules within the DC remain incompletely elucidated [136].”
Zhou, S., Eid, K., & Glowacki, J. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301239 · Cited by 226 · cited 1×
“Additionally, it enhances nuclear accumulation and stability of β-catenin in human marrow stromal cells [172].”
BackgroundmiR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Cao, M.-Q., You, A.-B., Zhu, X.-D., Zhang, W., Zhang, Y.-Y., Zhang, S.-Z., Zhang, K.-W., Cai, H., Shi, W.-K., Li, X.-L., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0555-y · Cited by 226 · cited 1×
“This inhibition subsequently potentiates the interaction between β-catenin and TCF4, ultimately leading to Wnt signaling activation [149].”
BackgroundDishevelled promotes axon differentiation by regulating atypical protein kinase C
Zhang, X., Zhu, J., Yang, G.-Y., Wang, Q.-J., Qian, L., Chen, Y.-M., Chen, F., Tao, Y., Hu, H.-S., Wang, T., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1603 · Cited by 220 · cited 1×
“DVL recruits the components of DC to the cell membrane by binding to the cytoplasmic carboxyl end of the FZD protein through its PDZ domain, thereby modulating the Wnt signaling pathway [41, 296].”
BackgroundAcetylation of β-Catenin by p300 Regulates β-Catenin-Tcf4 Interaction
Lévy, L., Wei, Y., Labalette, C., Wu, Y., Renard, C.-A., Buendia, M. A., & Neuveut, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3404-3414.2004 · Cited by 220
Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas
Kahlert, U. D., Nikkhah, G., & Maciaczyk, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.010 · Cited by 219 · cited 1×
“GBM with mesenchymal features is characterized by a high degree of aggression and resistance towards treatment along with neural stem cell marker [264].”
BackgroundKamachi, Y., Ogawa, E., Asano, M., Ishida, S., Murakami, Y., Satake, M., Ito, Y., & Shigesada, K. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4808-4819.1990 · Cited by 218 · cited 1×
“It is crucial for binding to core binding factor beta (CBFβ) and DNA [75].”
BackgroundTargeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma
Sukhdeo, K., Mani, M., Zhang, Y., Dutta, J., Yasui, H., Rooney, M. D., Carrasco, D. E., Zheng, M., He, H., Tai, Y.-T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610299104 · Cited by 216
Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
Grandy, D., Shan, J., Zhang, X., Rao, S., Akunuru, S., Li, H., Zhang, Y., Alpatov, I., Zhang, X. A., Lang, R. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009647 · Cited by 201
Dihlmann, S., Siermann, A., & von Knebel Doeberitz, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204123 · Cited by 199
The Role of Ryk and Ror Receptor Tyrosine Kinases in Wnt Signal Transduction
Green, J., Nusse, R., & van Amerongen, R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009175 · Cited by 196 · cited 1×
“This three-component complex would contribute to rapid endocytosis and subsequent removal of this protein from the plasma membrane [67, 68].”
BackgroundJiang, X., Charlat, O., Zamponi, R., Yang, Y., & Cong, F. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.015 · Cited by 193 · cited 2×
“DVL recruits the components of DC to the cell membrane by binding to the cytoplasmic carboxyl end of the FZD protein through its PDZ domain, thereby modulating the Wnt signaling pathway [41, 296].”
BackgroundYing, J., Li, H., Yu, J., Ng, K. M., Poon, F. F., Wong, S. C. C., Chan, A. T. C., Sung, J. J. Y., & Tao, Q. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1644 · Cited by 193 · cited 2×
“Nota-bly, hypermethylation of the Wnt5a promoter is universally observed in CRC tissues [103, 104].”
BackgroundRegulation of Lrp6 phosphorylation
Niehrs, C., & Shen, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0329-3 · Cited by 193 · cited 1×
“Within the intracellular domain of LRP5/6, the serine/threonine phosphorylation of the PPPSxPS motif is conserved, providing a docking site for AXIN binding [36] as well as presenting a critical step in initiating Wnt/β-catenin signal transduction [37, 38].”
BackgroundCai, J., Fang, L., Huang, Y., Li, R., Xu, X., Hu, Z., Zhang, L., Yang, Y., Zhu, X., Zhang, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15870 · Cited by 193 · cited 1×
“In addition, miR-455-3p and miR-1246 have been identified to target GSK3β [103,104], while miR-128-3p has been certified to regulate AXIN [146].”
BackgroundSelf-citationAberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
van Andel, H., Kocemba, K. A., Spaargaren, M., & Pals, S. T. (2019) · Leukemia · doi:10.1038/s41375-019-0404-1 · Cited by 188 · cited 1×
“The physiological mechanism associated with DKK1 involves the activation of DKK1 transcription through the Wnt/β-catenin signaling pathway, which then binds to LRP5/6 and blocks the recognition of Wnt ligands, thereby forming a negative feedback loop that inhibits Wnt signaling [352].”
BackgroundOctamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells
Chai, S., Ng, K., Tong, M., Lau, E. Y., Lee, T. K., Chan, K. W., Yuan, Y., Cheung, T., Cheung, S., Wang, X., et al. (2016) · Hepatology · doi:10.1002/hep.28821 · Cited by 188
Jeong, W.-J., Yoon, J., Park, J.-C., Lee, S.-H., Lee, S.-H., Kaduwal, S., Kim, H., Yoon, J.-B., & Choi, K.-Y. (2012) · Science Signaling · doi:10.1126/scisignal.2002242 · Cited by 188 · cited 1×
“Phosphorylated H-Ras recruits the E3 ligase linker protein β-trcp for its polyubiquitylation and subsequent degradation [191].”
BackgroundBachmann, I. M., Straume, O., Puntervoll, H. E., Kalvenes, M. B., & Akslen, L. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0011 · Cited by 188 · cited 1×
“The role of β-catenin in the later stages of melanoma development remains controversial, as some studies propose that elevated levels of β-catenin in melanoma are associated with a lower proliferative index [243] or a better prognosis [244].”
BackgroundDNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer
Wang, Q., Liang, N., Yang, T., Li, Y., Li, J., Huang, Q., Wu, C., Sun, L., Zhou, X., Cheng, X., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.06.025 · Cited by 188 · cited 1×
“More importantly, the Lysine acetylation Neuroblastoma Upregulation [114, 115] variation of expression BEX1 in different types of HCC has been certified to be associated with DNMT1-medi-ated DNA methylation [134].”
BackgroundAcetylation of β-Catenin by CREB-binding Protein (CBP)
Wolf, D., Rodova, M., Miska, E. A., Calvet, J. P., & Kouzarides, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201196200 · Cited by 186
Xu, D., Yang, F., Yuan, J.-H., Zhang, L., Bi, H.-S., Zhou, C.-C., Liu, F., Wang, F., & Sun, S.-H. (2013) · Hepatology · doi:10.1002/hep.26361 · Cited by 185 · cited 1×
“Consequently, this event leads to an elevation in cytoplasmic β-catenin concentration, subsequently enhancing the transcription of c-Myc and Cyclin D1 [155].”
BackgroundWnt Signalosome Assembly by DEP Domain Swapping of Dishevelled
Gammons, M. V., Renko, M., Johnson, C. M., Rutherford, T. J., & Bienz, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.026 · Cited by 184 · cited 2×
“When Wnt ligands bind, DVL is recruited to the plasma membrane, contributing to the formation of clathrin-coated pits, thereby facilitating FZD clustering and LRP6 phosphorylation [29, 33, 39, 40].”
BackgroundLv, C., Li, F., Li, X., Tian, Y., Zhang, Y., Sheng, X., Song, Y., Meng, Q., Yuan, S., Luan, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01059-5 · Cited by 183 · cited 1×
“In breast cancer, miR-183 has been identified as a direct inhibitor of key components of the DC, including AXIN1, AXIN2, and GSK3β, to activate the canonical Wnt signaling [139, 140].”
BackgroundDijksterhuis, J. P., Petersen, J., & Schulte, G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12364 · Cited by 182 · cited 3×
“The DVL protein family comprises three members: DVL-1, DVL-2, and DVL-3, which can bind to FZD and regulate small GTPases [34].”
BackgroundProtein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus
Li, X., Yost, H. J., Virshup, D. M., & Seeling, J. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4122 · Cited by 180 · cited 1×
“Moreover, it is epistatically positioned downstream of GSK3β but upstream of β-catenin [74].”
BackgroundArqués, O., Chicote, I., Puig, I., Tenbaum, S. P., Argilés, G., Dienstmann, R., Fernández, N., Caratù, G., Matito, J., Silberschmidt, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3081 · Cited by 178 · cited 1×
“Several TNKS inhibitors with favorable therapeutic effects have been developed, including XAV939, G007LK, G244-LM, RK-287,107, JW55, K-756, IWR-1, MSC2504877, AZ1366, JW74, and NVP-TNKS656 [308–317].”
BackgroundAi, L., Tao, Q., Zhong, S., Fields, C. R., Kim, W.-J., Lee, M. W., Cui, Y., Brown, K. D., & Robertson, K. D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi379 · Cited by 176
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Lenz, H., & Kahn, M. (2014) · Cancer Science · doi:10.1111/cas.12471 · Cited by 175 · cited 1×
“PRI-724 serves as a pioneer small molecule antagonist, similar to ICG-001 [335].”
BackgroundBasu, S., Cheriyamundath, S., & Ben-Ze’ev, A. (2018) · F1000Research · doi:10.12688/f1000research.15782.1 · Cited by 174 · cited 1×
“Additionally, this pathway is closely connected with the degradation of extracellular matrix, cancer cell migration and adhesion, as well as tumor angiogenesis [193].”
BackgroundAutophagy and the Wnt signaling pathway: A focus on Wnt/β-catenin signaling
Lorzadeh, S., Kohan, L., Ghavami, S., & Azarpira, N. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118926 · Cited by 173 · cited 3×
“It has been demonstrated robust autophagy can result from nutrient deficiency or the administration of mTOR inhibitors in GBM cells [260].”
BackgroundInfluentialWNT5A Expression Increases during Melanoma Progression and Correlates with Outcome
Da Forno, P. D., Pringle, J. H., Hutchinson, P., Osborn, J., Huang, Q., Potter, L., Hancox, R. A., Fletcher, A., & Saldanha, G. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5104 · Cited by 170 · cited 1×
“It is widely postulated that distinct Wnt signaling pathways are harnessed by melanoma cells at different stages of disease advancement; canonical Wnt signaling predominantly facilitates growth and transformation to augment their proliferative capacity [247, 248].”
BackgroundIs β-Catenin a Druggable Target for Cancer Therapy?
Cui, C., Zhou, X., Zhang, W., Qu, Y., & Ke, X. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.06.003 · Cited by 168 · cited 1×
“Therefore, the clinical application of these therapies is limited [358, 359].”
BackgroundHung, S. W., Zhang, R., Tan, Z., Chung, J. P. W., Zhang, T., & Wang, C. C. (2021) · Medicinal Research Reviews · doi:10.1002/med.21802 · Cited by 167 · cited 2×
“Curcumin exhibits interference with the Wnt pathway and E-cadherin regulation, effectively suppressing the growth and invasion of CRC cells [355, 356].”
BackgroundWnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer
He, K., & Gan, W.-J. (2023) · Cancer Management and Research · doi:10.2147/cmar.s411168 · Cited by 167 · cited 2×
“Furthermore, the Wnt/β-catenin signaling pathway exhibits crosstalk with other pathways and actively participates in the regulation of tumor microenvironment [210, 211].”
BackgroundModular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1
Malinauskas, T., Aricescu, A. R., Lu, W., Siebold, C., & Jones, E. Y. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2081 · Cited by 165 · cited 2×
“These specific domains facilitate the binding of sFRPs and WIF to the Wnt protein [50, 51].”
BackgroundJang, G.-B., Hong, I.-S., Kim, R.-J., Lee, S.-Y., Park, S.-J., Lee, E.-S., Park, J. H., Yun, C.-H., Chung, J.-U., Lee, K.-J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2041 · Cited by 163 · cited 1×
“Therefore, this study suggests that targeting β-catenin may hold significant therapeutic potential for addressing cancer metastasis, recurrence, and drug resistance in breast cancer associated with CSCs [233].”
BackgroundCholestasis is a marker for hepatocellular carcinomas displaying β‐catenin mutations
Audard, V, Grimber, G., Elie, C., Radenen, B., Audebourg, A., Letourneur, F., Soubrane, O., Vacher‐Lavenu, M., Perret, C., Cavard, C., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2169 · Cited by 162 · cited 1×
“Importantly, CTNNB1 mutation may impact the pathological presentation of HCC. Audard et al. demonstrated that CTNNB1-mutated HCCs typically manifest as large solitary lesions ( > 6 cm in diameter) [219].”
BackgroundDirect targeting of β ‐catenin in the Wnt signaling pathway: Current progress and perspectives
Wang, Z., Li, Z., & Ji, H. (2021) · Medicinal Research Reviews · doi:10.1002/med.21787 · Cited by 162 · cited 1×
“By competitively binding to Wnt ligands, it negatively regulates the Wnt/β-catenin signaling transduction and disrupts the function of LRPs/FZDs [347, 350].”
BackgroundWei, C.-Y., Zhu, M.-X., Yang, Y.-W., Zhang, P.-F., Yang, X., Peng, R., Gao, C., Lu, J.-C., Wang, L., Deng, X.-Y., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0711-z · Cited by 161 · cited 1×
“This process is considered to promote melanoma progression and is significantly associated with a poor prognosis in melanoma patients [242].”
BackgroundPromoter Methylation in APC, RUNX3, and GSTP1 and Mortality in Prostate Cancer Patients
Richiardi, L., Fiano, V., Vizzini, L., De Marco, L., Delsedime, L., Akre, O., Tos, A. G., & Merletti, F. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2485 · Cited by 160 · cited 1×
“In lung carcinoma, APC promoter methylation has been correlated with smoking status and non-metastatic cases [122], while methylation in APC has been observed to be associated with an increased risk of prostate cancer-specific mortality [123].”
BackgroundHan, M., Wang, S., Fritah, S., Wang, X., Zhou, W., Yang, N., Ni, S., Huang, B., Chen, A., Li, G., et al. (2020) · Brain · doi:10.1093/brain/awz406 · Cited by 158
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
Li, X., Placencio, V, Iturregui, J. M., Uwamariya, C., Sharif-Afshar, A.-R., Koyama, T., Hayward, S. W., & Bhowmick, N. A. (2008) · Oncogene · doi:10.1038/onc.2008.293 · Cited by 156 · cited 2×
“In prostate carcinoma, the activity of Stat3 located on the Wnt3a promoter is inhibited by TGF-β, resulting in a reduction of Wnt3a levels in tissues and subsequent suppression of tumor progression [174].”
BackgroundInactive Wnt/β‐catenin pathway in conventional high‐grade osteosarcoma
Cai, Y., Mohseny, A. B., Karperien, M., Hogendoorn, P. C., Zhou, G., & Cleton‐Jansen, A. (2010) · The Journal of Pathology · doi:10.1002/path.2628 · Cited by 155 · cited 1×
“In conventional high-grade OS, the Wnt/β-catenin pathway is inhibited while reactivation of this pathway has been demonstrated to suppress cancer cell proliferation [276].”
BackgroundWLS Retrograde Transport to the Endoplasmic Reticulum during Wnt Secretion
Yu, J., Chia, J., Canning, C. A., Jones, C. M., Bard, F., & Virshup, D. M. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.03.016 · Cited by 154 · cited 1×
“It is essential for the binding of lipid-modified Wnts and facilitates endoplasmic reticulum retrograde trafficking [31].”
BackgroundWang, J., Cai, H., Liu, Q., Xia, Y., Xing, L., Zuo, Q., Zhang, Y., Chen, C., Xu, K., Yin, P., et al. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500354 · Cited by 153
Webster, M.-T., Rozycka, M., Sara, E., Davis, E., Smalley, M., Young, N., Dale, T. C., & Wooster, R. (2000) · Genes, Chromosomes and Cancer · doi:10.1002/1098-2264(200008)28:4<443::aid-gcc10>3.0.co;2-d · Cited by 153 · cited 1×
“AXIN has been identified with mutations in various carcinoma types including hepatocellular carcinoma (HCC), CRC, medulloblastomas, and ovarian endometrioid adenocarcinoma [86–91].”
BackgroundDi, L.-J., Byun, J. S., Wong, M. M., Wakano, C., Taylor, T., Bilke, S., Baek, S., Hunter, K., Yang, H., Lee, M., et al. (2013) · Nature Communications · doi:10.1038/ncomms2438 · Cited by 151 · cited 1×
“The aberrant activation of the Wnt/catenin pathway in breast cancer is predominantly induced by epigenetic alterations in constituent elements, such as C-terminal binding protein [227] and Groucho-related transcriptional repressor protein [228].”
BackgroundTiki1 Is Required for Head Formation via Wnt Cleavage-Oxidation and Inactivation
Zhang, X., Abreu, J. G., Yokota, C., MacDonald, B. T., Singh, S., Coburn, K. L. A., Cheong, S.-M., Zhang, M. M., Ye, Q.-Z., Hang, H. C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.039 · Cited by 150 · cited 1×
“Tiki represents a family of Wnt-specific proteases that would directly inhibit Wnt signaling by hydrolyzing the terminal of Wnt3a and triggering the transformation of Wnt3a into oxidized oligomers, thereby depriving its ability to bind receptors [54, 55].”
BackgroundWu, Z., Wei, D., Gao, W., Xu, Y., Hu, Z., Ma, Z., Gao, C., Zhu, X., & Li, Q. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.016 · Cited by 149 · cited 1×
“The acetylation of LRP6 is promoted by p300, subsequently triggering its phosphorylation for signal responsiveness [131].”
BackgroundSuppressing Wnt Signaling by the Hedgehog Pathway through sFRP-1
He, J., Sheng, T., Stelter, A. A., Li, C., Zhang, X., Sinha, M., Luxon, B. A., & Xie, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600200200 · Cited by 149 · cited 1×
“It has been demonstrated that sFRP-1, induced by HH transcription, functions as a negative regulator of the Wnt pathway [182].”
BackgroundRegulation of β-Catenin Function by the IκB Kinases
Lamberti, C., Lin, K.-M., Yamamoto, Y., Verma, U., Verma, I. M., Byers, S., & Gaynor, R. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104227200 · Cited by 147
IKKα Regulates Mitogenic Signaling through Transcriptional Induction of Cyclin D1 via Tcf
Albanese, C., Wu, K., D'Amico, M., Jarrett, C., Joyce, D., Hughes, J., Hulit, J., Sakamaki, T., Fu, M., Ben-Ze'ev, A., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-06-0101 · Cited by 145 · cited 1×
“Research has suggested that IKKα specifically enhances the transcriptional activity of β-catenin/ TCF and induces upregulation of CCND1, a down-stream target gene encoding cyclin D1 [189].”
BackgroundWei, W., Chua, M., Grepper, S., & So, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.24810 · Cited by 141 · cited 2×
“PKF115-854 and CGP049090 have also presented inhibitory effects on HCC cell growth [327, 328].”
BackgroundStructure and function of Norrin in assembly and activation of a Frizzled 4–Lrp5/6 complex
Ke, J., Harikumar, K. G., Erice, C., Chen, C., Gu, X., Wang, L., Parker, N., Cheng, Z., Xu, W., Williams, B. O., et al. (2013) · Genes & Development · doi:10.1101/gad.228544.113 · Cited by 140 · cited 1×
“The Norrin protein, which mimics the fingerlike-loop structure of Wnt, exhibits the capability to bind to both the CRD domain of FZD4 and the ectodomain of LRP5/6, forming a ternary complex that facilitates downstream signal transmission of Wnt/ β-catenin [51, 64, 65].”
BackgroundAXIN1 and AXIN2 variants in gastrointestinal cancers
Mazzoni, S. M., & Fearon, E. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.018 · Cited by 140 · cited 1×
“Mutations in the AXIN1 or AXIN2 genes have been detected across various types of cancers [199].”
BackgroundLoss of beta-catenin expression associated with disease progression in malignant melanoma
Kageshita, T., Hamby, C. V., Ishihara, T., Matsumoto, K., Saida, T., & Ono, T. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04336.x · Cited by 137 · cited 1×
“However, numerous studies have demonstrated that the oncogenic role of β-catenin in melanoma [245, 246].”
BackgroundFOXKs Promote Wnt/β-Catenin Signaling by Translocating DVL into the Nucleus
Wang, W., Li, X., Lee, M., Jun, S., Aziz, K. E., Feng, L., Tran, M. K., Li, N., McCrea, P. D., Park, J.-I., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.031 · Cited by 137
Romero, F. A., Murray, J., Lai, K. W., Tsui, V., Albrecht, B. K., An, L., Beresini, M. H., de Leon Boenig, G., Bronner, S. M., Chan, E. W., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00796 · Cited by 136
Self-citationYu, J. Q., Tao, Q., Cheng, Y. Y., Lee, K. Y., Ng, S. S. M., Cheung, K. F., Tian, L., Rha, S. Y., Neumann, U. P., Röcken, C., et al. (2008) · Cancer · doi:10.1002/cncr.23989 · Cited by 130 · cited 1×
“It has been proven to be related to poor prognosis [106–108].”
BackgroundUSP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin
Ji, L., Lu, B., Zamponi, R., Charlat, O., Aversa, R., Yang, Z., Sigoillot, F., Zhu, X., Hu, T., Reece-Hoyes, J. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12143-3 · Cited by 127 · cited 1×
“AXIN, a rate-limiting scaffolding protein within the complex, is continuously regulated by TNKS [304–306].”
BackgroundLuo, Y., Huang, S., Wei, J., Zhou, H., Wang, W., Yang, J., Deng, Q., Wang, H., & Fu, Z. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.752 · Cited by 127 · cited 1×
“It has been reported that lncRNA-LINC01606 can compete with miR-423‐5p, contributing to the upregulation of Colon cancer [160] stearoyl‐CoA desaturase 1 and activation of the canonical Wnt/β‐catenin signaling pathway [160].”
BackgroundMutation Hotspots in the β-Catenin Gene: Lessons from the Human Cancer Genome Databases.
Kim, S., & Jeong-Yu, S. (2019) · PubMed · doi:10.14348/molcells.2018.0436 · Cited by 127 · cited 1×
“Clinical data indicates that approximately 70% of both sporadic and hereditary colorectal cancers exhibit deletions or mutations in the APC gene [197].”
BackgroundTao, J., Xu, E., Zhao, Y., Singh, S., Li, X., Couchy, G., Chen, X., Zucman‐Rossi, J., Chikina, M., & Monga, S. P. S. (2016) · Hepatology · doi:10.1002/hep.28601 · Cited by 125 · cited 1×
“The activation of Wnt/β-catenin alone is insufficient to drive hepatocarcinogenesis; instead, its interactions with c-Met, K-RasV12, activated Akt, LKB1, and Nrf2 are necessary for HCC formation in mice. c-Met c-Met has been observed in 10% of human HCC tissue samples [220–224].”
BackgroundChang, T.-H., Hsieh, F.-L., Zebisch, M., Harlos, K., Elegheert, J., & Jones, E. Y. (2015) · eLife · doi:10.7554/elife.06554 · Cited by 125 · cited 1×
“The Norrin protein, which mimics the fingerlike-loop structure of Wnt, exhibits the capability to bind to both the CRD domain of FZD4 and the ectodomain of LRP5/6, forming a ternary complex that facilitates downstream signal transmission of Wnt/ β-catenin [51, 64, 65].”
BackgroundLi, N., Wei, L., Liu, X., Bai, H., Ye, Y., Li, D., Li, N., Baxa, U., Wang, Q., Lv, L., et al. (2019) · Hepatology · doi:10.1002/hep.30646 · Cited by 124 · cited 1×
“Additionally, GPC3 regulates the Wnt activation according to the concentration dynamically by interacting with FZD through the heparan sulfate chain [53].”
BackgroundIn melanoma, beta-catenin is a suppressor of invasion
Arozarena, I., Bischof, H., Gilby, D., Belloni, B., Dummer, R., & Wellbrock, C. (2011) · Oncogene · doi:10.1038/onc.2011.162 · Cited by 121 · cited 1×
“However, numerous studies have demonstrated that the oncogenic role of β-catenin in melanoma [245, 246].”
Wnt Signaling: Physiology and Pathology
Prunier, C., Hocevar, B. A., & Howe, P. H. (2004) · Growth Factors · doi:10.1080/08977190410001720860 · Cited by 121 · cited 1×
“There is substantial evidence supporting its involvement in multiple signaling pathways mediated by receptors [72].”
BackgroundWnt/β-catenin signaling in melanoma: Preclinical rationale and novel therapeutic insights
Xue, G., Romano, E., Massi, D., & Mandalà, M. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.06.009 · Cited by 120 · cited 2×
“The Wnt signaling pathway governs the migration of neural crest melanocytes to the hair and epidermal follicles, where they facilitate cellular differentiation and generate skin and hair pigment [240].”
Backgroundβ-Catenin Signalling in Glioblastoma Multiforme and Glioma-Initiating Cells
Nàger, M., Bhardwaj, D., Cantí, C., Medina, L. M., Nogués, P., & Herreros, J. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/192362 · Cited by 120 · cited 1×
“Wnt5a modulates the synthesis of matrix metalloproteinase-2 (MMP-2), thereby enhancing glioma cell migration [262].”
BackgroundTargeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia
Salik, B., Yi, H., Hassan, N., Santiappillai, N., Vick, B., Connerty, P., Duly, A., Trahair, T., Woo, A. J., Beck, D., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.014 · Cited by 119 · cited 1×
“It plays an indispensable role in a wide range of physiological processes encompassing proliferation, differentiation, apoptosis, migration, invasion and tissue homeostasis [1–3].”
BackgroundAbitbol, S., Dahmani, R., Coulouarn, C., Ragazzon, B., Mlecnik, B., Senni, N., Savall, M., Bossard, P., Sohier, P., Drouet, V., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.018 · Cited by 118 · cited 2×
“In AXIN1-deleted mice, 40% of mutated mice developed HCC, while none of the control monogenic mice exhibited HCC development [225].”
BackgroundShah, K., Panchal, S., & Patel, B. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105532 · Cited by 118 · cited 1×
“Other PORCN small molecule inhibitors, including IWP compounds, RXC004, and Wnt-C59, have been identified for their ability to block Wnt secretion by inhibiting the acylation of Wnt proteins [285–287].”
BackgroundTranscriptional Regulation by Smads: Crosstalk between the TGF-β and Wnt Pathways
Letamendia, A., Labbé, E., & Attisano, L. (2001) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200100001-00005 · Cited by 116 · cited 1×
“Smad can interact with LEF1/TCF transcription factor which is essential for synergistic activation by both TGF-β and the Wnt/β-catenin pathway [173].”
BackgroundYao, X., Mao, Y., Wu, D., Zhu, Y., Lu, J., Huang, Y., Guo, Y., Wang, Z., Zhu, S., Li, X., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.030 · Cited by 116 · cited 1×
“Similarly, miR-388-5p has been verified to downregulate the expression of WIF1 while promoting Wnt8 expression, thereby leading to subsequent activation of this pathway in pancreatic cancer [138].”
BackgroundSelf-citationThe CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth
Arensman, M. D., Telesca, D., Lay, A. R., Kershaw, K. M., Wu, N., Donahue, T. R., & Dawson, D. W. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1005 · Cited by 115 · cited 1×
“INT-001, a selective antagonist of CBP, demonstrated significant antitumoral activity in various preclinical models including pancreatic, colon, and tamoxifen-resistant breast cancers [339, 340].”
BackgroundGandhirajan, R. K., Staib, P. A., Minke, K., Gehrke, I., Plickert, G., Schlösser, A., Schmitt, E. K., Hallek, M., & Kreuzer, K.-A. (2010) · Neoplasia · doi:10.1593/neo.91972 · Cited by 115
PCAF Acetylates β-Catenin and Improves Its Stability
Ge, X., Jin, Q., Zhang, F., Yan, T., & Zhai, Q. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0792 · Cited by 114 · cited 1×
“Additionally, both K19 and K49 play crucial roles as essential residues during the acetylation process mediated by PCAF [129].”
BackgroundShen, J., Sun, Y., Liu, X., Zhu, Y. M., Bao, B., Gao, T., Chai, Y., Xu, J., & Zheng, X. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02487-3 · Cited by 114
Development of anticancer agents targeting the Wnt/β-catenin signaling.
Zhang, X., & Hao, J. (2015) · Europe PMC (PubMed Central) · Cited by 109
Novel insight into the function of tankyrase (Review)
Kim, M. K. (2018) · Oncology Letters · doi:10.3892/ol.2018.9551 · Cited by 109 · cited 1×
“TNKS primarily contribute to the degradation of AXIN protein, and its inhibition leads to the stabilization of AXIN, thereby antagonizing Wnt signaling [307].”
BackgroundChong, J. M., Üren, A., Rubin, J. S., & Speicher, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108533200 · Cited by 108 · cited 1×
“These specific domains facilitate the binding of sFRPs and WIF to the Wnt protein [50, 51].”
BackgroundCytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis
Iwaya, K., Ogawa, H., Kuroda, M., Izumi, M., Ishida, T., & Mukai, K. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025821229013 · Cited by 107 · cited 1×
“Numerous studies have demonstrated that dysregulated activation of the canonical Wnt signaling pathway contributes to both the development and metastasis of OS [268, 269].”
BackgroundEpigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability
Koinuma, K., Yamashita, Y., Liu, W., Hatanaka, H., Kurashina, K., Wada, T., Takada, S., Kaneda, R., Choi, Y. L., Fujiwara, S.-I., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209009 · Cited by 106 · cited 1×
“As a crucial component of DC, methylation of AXIN2 leads to the silencing of AXIN2 expression, particularly in MSI CRC specimens [124].”
BackgroundBrennan, K., Gonzalez-Sancho, J. M., Castelo-Soccio, L. A., Howe, L. R., & Brown, A. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207642 · Cited by 103 · cited 1×
“Within the intracellular domain of LRP5/6, the serine/threonine phosphorylation of the PPPSxPS motif is conserved, providing a docking site for AXIN binding [36] as well as presenting a critical step in initiating Wnt/β-catenin signal transduction [37, 38].”
BackgroundSulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein Dishevelled
Lee, H., Wang, N. X., Shi, D., & Zheng, J. J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200902981 · Cited by 100 · cited 1×
“In addition, sulindac, as an SMI, effectively impedes the β-catenin signal transduction pathway triggered by Wnt3a at the DVL level [303].”
BackgroundHashizume, R., Koizumi, H., Ihara, A., Ohta, T., & Uchikoshi, T. (1996) · Histopathology · doi:10.1046/j.1365-2559.1996.d01-499.x · Cited by 100
Francis, J. C., Thomsen, M. K., Taketo, M. M., & Swain, A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003180 · Cited by 100 · cited 1×
“Prostate cancer β-catenin proteins play an indispensable role in embryonic prostate development, whereas its overexpression contributes to invasive prostate cancer development [234].”
BackgroundWnt Signaling in Renal Cell Carcinoma
Xu, Q., Krause, M., Samoylenko, A., & Vainio, S. (2016) · Cancers · doi:10.3390/cancers8060057 · Cited by 99 · cited 1×
“Cytoplasmic accumulation of β-catenin is considered a promising therapeutic approach due to their potential role in maintaining cellular homeostasis [256].”
BackgroundFujikane, T., Nishikawa, N., Toyota, M., Suzuki, H., Nojima, M., Maruyama, R., Ashida, M., Ohe-Toyota, M., Kai, M., Nishidate, T., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0600-1 · Cited by 99
The role of WNT10B in physiology and disease
Wend, P., Wend, K., Krum, S. A., & Miranda‐Carboni, G. A. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02296.x · Cited by 97 · cited 1×
“Wnt10b plays a pivotal role in regulating the signaling network governing stemness, pluripotency, and cell fate in various organs [49].”
BackgroundWnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials
Neiheisel, A., Kaur, M., Ma, N., Havard, P., & Shenoy, A. K. (2022) · International Journal of Cancer · doi:10.1002/ijc.33811 · Cited by 96 · cited 1×
“Other PORCN small molecule inhibitors, including IWP compounds, RXC004, and Wnt-C59, have been identified for their ability to block Wnt secretion by inhibiting the acylation of Wnt proteins [285–287].”
BackgroundLü, L., Gao, Y., Zhang, Z., Cao, Q., Zhang, X., Zou, J., & Cao, Y. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.04.006 · Cited by 95 · cited 2×
“Importantly, evidence suggests that even without demethylation, Kdm2a/b-mediated destruction of the β-catenin/TCF complex inhibits Wnt signaling [80].”
BackgroundOsawa, Y., Oboki, K., Imamura, J., Kojika, E., Hayashi, Y., Hishima, T., Saibara, T., Shibasaki, F., Kohara, M., & Kimura, K. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.010 · Cited by 94 · cited 2×
“Upon phosphorylation, PRI-724 undergoes rapid hydrolysis in vivo to convert into its active form known as C-82 to inhibit the interaction between β-catenin and CBP [336].”
BackgroundLiu, A., Zhu, J., Wu, G., Cao, L., Tan, Z., Zhang, S., Jiang, L., Wu, J., Li, M., Song, L., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0669-9 · Cited by 94
Research works printed but not linked: 6
- Nusse R Clevers H Wnt/beta-Catenin signaling, Disease, and emerging therapeutic modalities Cell 2017 169 6 985 99 10.1016/j.cell.2017.05.016 28575679 · DOI · Paper page
- Cai J Fang L Huang Y Li R Xu X Hu Z Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by mir-128-3p confers chemoresistance-associated metastasis in NSCLC Nat Commun 2017 8 15870 10.1038/ncomms15870 28627514 PMC5481840 · DOI · Paper page
- Chai S Ng KY Tong M Lau EY Lee TK Chan KW Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells Hepatology 2016 64 6 2062 76 10.1002/hep.28821 27639189 · DOI · Paper page
- Wang Z Li Z Ji H Direct targeting of β-catenin in the wnt signaling pathway: current progress and perspectives Med Res Rev 2021 41 4 2109 29 10.1002/med.21787 33475177 PMC8217106 · DOI
- Jung YS Park JI Wnt signaling in cancer: therapeutic targeting of wnt signaling beyond β-catenin and the destruction complex Exp Mol Med 2020 52 2 183 91 10.1038/s12276-020-0380-6 32037398 PMC7062731 · DOI · Paper page
- Zhao H Ming T Tang S Ren S Yang H Liu M Wnt signaling in colorectal cancer: pathogenic role and therapeutic target Mol Cancer 2022 21 1 144 10.1186/s12943-022-01616-7 35836256 PMC9281132 · DOI · Paper page
Cited by
Helicobacter pylori and gastric cancer: mechanisms and new perspectives
Duan, Y., Xu, Y., Dou, Y., & Xu, D. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01654-2 · Cited by 300
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., Kang, W., Lee, J.-M., Youn, H., & Youn, B. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02360-2 · Cited by 188
Yu, B., & Ma, W. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.08.006 · Cited by 121
Cell migration in diabetic wound healing: Molecular mechanisms and therapeutic strategies (Review)
Song, J., Zhao, T., Wang, C., Sun, X., Sun, J., & Zhang, Z. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5567 · Cited by 116
“7) (146).”
Galasso, L., Termite, F., Mignini, I., Esposto, G., Borriello, R., Vitale, F., Nicoletti, A., Paratore, M., Ainora, M. E., Gasbarrini, A., et al. (2025) · Cancers · doi:10.3390/cancers17030368 · Cited by 90
“Activation of this pathway by F. nucleatum has been associated with poor outcomes in CRC patients due to its role in driving uncontrolled tumor growth and metastasis [23,24].”
Metadata
- Authors
- Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X.
- Affiliations
- West China Hospital of Sichuan University (CN)
- Sichuan University (CN)
- Corresponding author
- Dong, Qiang
- Wei, Xiawei
- Venue
- Journal of Hematology & Oncology
- Published
- 2024-06-18
- Volume
- 17
- Issue
- 1
- Pages
- 46-46
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC11184729
- OpenAlex
- W4399792819
- Cited by
- 382
- References
- 354
- Citations by year
- 2026: 167 · 2025: 193 · 2024: 22
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Foundation for Excellent Young Scholars (32122052)
- National Natural Science Foundation Regional Innovation and Development (No. U19A2003)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt/β-catenin signaling, carcinogenesis, cancer therapy, targeted therapy, tumor initiation and progression, epigenetic modifications, signaling crosstalk, Wnt inhibitors, cell proliferation, tissue homeostasis
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, beta Catenin, Molecular Targeted Therapy, Wnt Signaling Pathway, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.